Agreement On EU’s Radical Pharma Reform Plans ‘Could Take Three Years’
The controversial nature of some of the plans in the EU medicines legislative overhaul suggests a long road ahead for negotiations at the European Parliament and Council, with some “substantial amendments” likely along the way.
